Compare ATAI & CCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATAI | CCC |
|---|---|---|
| Founded | 2018 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2025 | 2020 |
| Metric | ATAI | CCC |
|---|---|---|
| Price | $7.34 | $7.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $15.88 | $8.94 |
| AVG Volume (30 Days) | 7.3M | ★ 9.7M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $4,089,000.00 | ★ $1,057,001,000.00 |
| Revenue This Year | N/A | $10.22 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | ★ N/A | $126.67 |
| Revenue Growth | ★ 1227.60 | 11.88 |
| 52 Week Low | $3.27 | $4.08 |
| 52 Week High | $7.45 | $8.68 |
| Indicator | ATAI | CCC |
|---|---|---|
| Relative Strength Index (RSI) | 67.09 | 66.93 |
| Support Level | $3.89 | $6.80 |
| Resistance Level | N/A | $7.68 |
| Average True Range (ATR) | 0.06 | 0.33 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 52.08 | 84.76 |
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.